This past year has brought many exciting new developments to the Diabetes Center at UCSF.  Recently, members of our team have improved a technique for genetically reprogramming mouse cells to become embryonic stem cells – a great advancement in stem cell research.  Additionally, numerous faculty members have received highly coveted national awards to further their cutting-edge research in both type 1 and type 2 diabetes.  And last but not least, private industry has recently embraced our drug that has been in development for well over a decade -- Anti-CD3.  This is the first exclusively type 1 diabetes treatment to progress this far in drug development!  

In this season where friends and family are so important, it is only fitting that we acknowledge the tremendous support of our extended family – patients, volunteers, and all of our supporters throughout the world.  It is through the unwavering generosity of so many of you that 2007 has been a year to remember at the Diabetes Center. 

On behalf of the faculty and staff of the Diabetes Center at UCSF, we wish you the healthiest and happiest holiday season.

Jeffrey A. Bluestone, PhD, Director, UCSF Diabetes Center